Pfizer Fights Off Shareholder Lawsuit

(Reuters) - Pfizer Inc won the dismissal Tuesday of a long-running shareholder class action accusing the company of misleading investors about the safety of its Celebrex and Bextra pain-relieving drugs.

The ruling by U.S. District Judge Laura Taylor Swain in New York came ahead of a Sept. 9 trial in the case, which investors launched in 2004 and followed an earlier ruling precluding testimony by the plaintiffs' damages expert.

Help employers find you! Check out all the jobs and post your resume.